Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001551163-20-000035

← back to feed
Filed
May 14, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · May 15, 2020 202.73M sh
Short Term Debt Q3 2020 · Mar 31, 2020 $565.17K
Short Term Debt Q3 2020 · Jun 30, 2019 $478.36K
Stockholders Equity Q3 2020 · Mar 31, 2020 −$19.54K
Stockholders Equity Q3 2020 · Jun 30, 2019 $49.2K
Current Liabilities Q3 2020 · Mar 31, 2020 $725.97K
Current Liabilities Q3 2020 · Jun 30, 2019 $670.96K
Total Liabilities Q3 2020 · Mar 31, 2020 $790.95K
Total Liabilities Q3 2020 · Jun 30, 2019 $670.96K
Current Assets Q3 2020 · Mar 31, 2020 $52.88K
Current Assets Q3 2020 · Jun 30, 2019 $78.97K
Total Assets Q3 2020 · Mar 31, 2020 $126.24K
Total Assets Q3 2020 · Jun 30, 2019 $78.97K
Cost Of Revenue Q3 2020 · Mar 31, 2020 $0
Cost Of Revenue Q3 2020 · Mar 31, 2020 $0
Cost Of Revenue Q3 2020 · Mar 31, 2019 $99
Cost Of Revenue Q3 2020 · Mar 31, 2019 $0
Operating Cash Flow Q3 2020 · Mar 31, 2019 −$236.39K
Cash And Equivalents Q3 2020 · Mar 31, 2019 $18.53K
Cash And Equivalents Q3 2020 · Jun 30, 2018 $20.94K
Sga Expense Q3 2020 · Mar 31, 2019 $37.52K
Sga Expense Q3 2020 · Mar 31, 2019 $127.92K
Rd Expense Q3 2020 · Mar 31, 2019 $5.09K
Rd Expense Q3 2020 · Mar 31, 2019 $20.38K
Net Income restated Q3 2020 · Mar 31, 2019 −$66.41K
Net Income restated Q3 2020 · Mar 31, 2019 −$212.73K
Operating Income Q3 2020 · Mar 31, 2019 −$74.15K
Operating Income Q3 2020 · Mar 31, 2019 −$227.79K
Gross Profit Q3 2020 · Mar 31, 2019 $8.16K
Gross Profit Q3 2020 · Mar 31, 2019 $63.43K
Revenue Q3 2020 · Mar 31, 2019 $8.06K
Revenue Q3 2020 · Mar 31, 2019 $63.43K